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NaCl stimulated the adenylate cyclase activities of human and rabbit platelet particulate fractions prepared 
in the presence of ethylene glycol bis(&aminoethyl ether)-N,N,N’,N’-tetraacetate, but inhibited the 
activities of particulate fractions proteolysed by endogenous Ca2+ -activated protease or treatment with cy- 
chymotrypsin. Studies with other monovalent cations howed that LiCl had weak effects imilar to those 
of NaCl, whereas KC1 inhibited the enzyme in both proteolysed and non-proteolysed preparations. The 
results suggest hat NaCl exerts stimulatory and inhibitory effects through different sites. NaCl potentiated 
and proteolysis greatly reduced the inhibition of platelet adenylate cyclase by I-0-octadecyl-2-O-acetyl-sn- 
glyceryl-3-phosphorylcholine (platelet-activating factor). 
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1. INTRODUCTION 
Treatment of a variety of cells and membrane 
preparations with proteolytic enzymes has been 
reported to enhance basal adenylate cyclase activi- 
ty and to modify the regulation of this enzyme by 
hormones and guanine nucleotides [I]. In the case 
of the rat platelet, incubation of homogenate with 
CaC12 caused a 2-7-fold increase in enzyme activi- 
ty that could be blocked by leupeptin or ZV- 
ethylmaleimide, indicating that this effect was at- 
tributable to the action of an endogenous 
Ca2+-dependent thiol protease [2]. In addition, ex- 
periments with human platelets have demonstrated 
that exogenous serine proteases block the inhibi- 
tion of PGEi-stimulated [3] and basal [4] adenylate 
cyclase activities by epinephrine. These effects 
were attributed to loss of the function of the Ni 
protein that couples inhibitory receptors to the 
catalytic moiety of adenylate cyclase [3,4]. In con- 
trast, receptor-mediated activation of the enzyme 
was unimpaired by proteolysis [3]. 
Abbreviations: I-octadecyl-2-acetyl-G-3-PC, I-O-octade- 
cyl-2-0-acetyl-sn-glyceryl-3-phosphorylcholine; EGTA, 
ethylene glycol bis@uninoethyl ether)-N, N, N ‘, N ‘- 
tetraacetic acid 
We have shown that I-octadecyl-2-acetyl- 
G-3-PC inhibits adenylate cyclase activity in par- 
ticulate fractions from both human and rabbit 
platelets [5]. This inhibition was observed with 
nanomolar concentrations of the compound and 
was structurally highly specific, suggesting that it 
was a receptor-mediated effect similar to that of 
epinephrine. However, the maximal inhibitions of 
basal activity observed were variable and relatively 
low (20-50%). Since limited proteolysis can sup- 
press the effects of inhibitory hormones on 
adenylate cyclase, we have investigated the 
possibility that endogenous proteolysis restricted 
the inhibition caused by this compound. In many 
biological systems, NaCl potentiates hormonal in- 
hibition of adenylate cyclase by stimulating basal 
enzyme activity in the presence of GTP, an effect 
that is reversed by the inhibitory hormone [6,7]. 
However, studies with the platelet system have in- 
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dicated that NaCl does not potentiate the in- 
hibitory action of epinephrine and inhibits basal 
and PGEi-stimulated adenylate cyclase activity 
[8,9]. In an attempt to enhance the inhibitory ef- 
fect of 1-octadecyl-2-acetyl-G-3-PC, we have re- 
investigated the action of NaCl on platelet 
adenylate cyclase and have found that the effects 
observed depend critically on whether or not the 
platelet membranes have been exposed to pro- 
teolytic enzymes. 
2. MATERIALS AND METHODS 
2.1. Materials 
Synthetic I-octadecyl-2-acetyl-G-3-PC was a 
generous gift from Dr H.R. Baumgartner of F. 
Hoffman-La Roche (Basel). Tris-ATP, Tris- 
phosphocreatine, cu-chymotrypsin, soybean trypsin 
inhibitor and leupeptin were obtained from Sigma 
(St. Louis, MO). [2,8-3H]ATP (26.6 Ci/mmol) 
was obtained from ICN (Irvine, CA). All other 
materials were obtained from sources listed in [5]. 
2.2. Preparation of platelet particulate fractions 
and assay of adenylate cyclase 
Rabbit and human platelets were isolated and 
washed as in [5] and were finally resuspended at 
25 mg wet wt/ml in 150 mM Tris-HCl (pH 7.4) 
containing either no other additions, 5 mM EGTA 
or 400 PM leupeptin. After freezing and thawing 
these suspensions and treatment of the lysates as 
described in the figure and table legends, the par- 
ticulate fractions were isolated by centrifugation at 
37500 x g for 40 min at 4°C and resuspended for 
assay of adenylate cyclase as in [5]. In addition to 
the compounds under investigatioa, adenylate 
cyclase assay mixtures (250~1) all contained 
75 mM Tris-HCl (pH 7.4), 5 mM MgClz, 0.4 mM 
Tris-[3H]ATP, 4 mM Tris-phosphocreatine, 20 
units of creatine phosphokinase/ml, 1 mM CAMP, 
1 mM 3-isobutyl-1-methylxanthine, 1 mg of 
crystallized bovine serum albumin/ml, 0.4 mM 
dithiothreitol, 10 PM GTP and 0.4 mM 
Tris-EGTA. After incubation for 10 min at 3O”C, 
assays were terminated and [3H]cAMP isolated 
and quantified [5]. The platelet protein present was 
measured as in [5]. All adenylate cyclase assays 
were carried out in triplicate; activities are given as 
means f SE. 
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3. RESULTS 
The basal adenylate cyclase activity of par- 
ticulate fractions from human platelets lysed in the 
absence of EGTA was about 3 times higher than 
the activity of fractions prepared in the presence of 
EGTA (table 1). NaCl had opposite effects on the 
activities of these two preparations, inhibiting the 
enzyme when EGTA was omitted and stimulating 
when EGTA was used. Addition of EGTA to the 
platelet lysis buffer and inclusion of NaCl in the 
assay medium both resulted in an enhanced inhibi- 
tion of human platelet adenylate cyclase by 
1 -octadecyl-2-acetyl-G-3-PC (table 1). Thus, 
100 mM NaCl increased the inhibition caused by 
400 nM 1-octadecyl-2-acetyl-G-3-PC from 16 to 
35% when EGTA was omitted, and from 28 to 
68% when EGTA was used. PGEi increased the 
adenylate cyclase activities of particulate fractions 
prepared with or without EGTA to similar extents. 
However, the stimulatory effect of NaCl was large- 
ly lost in the presence of PGEr, although its in- 
hibitory action was undiminished. The percentage 
inhibition of adenylate cyclase by 1 -octadecyl- 
2-acetyl-G-3-PC was always reduced in the presen- 
ce of PGEi (table 1). The effects of use of EGTA 
on both basal adenylate cyclase activity and the in- 
hibitory action of 1-octadecyl-2-acetyl-G-3-PC 
suggested that significant Ca’+-dependent pro- 
teolysis occurred when platelets were lysed in the 
absence of this compound. 
More detailed studies were carried out with the 
rabbit platelet enzyme. First, the actions of EGTA 
were compared with those of leupeptin to confirm 
that the former compound acted by inhibiting pro- 
teolysis. In the experiment shown in fig.1, platelet 
lysates were incubated for 15 min at 25°C to 
enhance any endogenous proteolysis. Under these 
conditions, particulate fraction from the control 
lysate had a basal adenylate cyclase activity 5-times 
higher than particulate fractions from lysates con- 
taining either 5 mM EGTA or 400pM leupeptin. 
Addition of lo-150 mM NaCl inhibited the activi- 
ty of the proteolysed preparation (maximum 45% 
at 50 mM) (fig.lA), but stimulated that of 
preparations from platelets lysed in the presence of 
either EGTA or leupeptin by up to ten-fold 
(fig. lB,C). With proteolysed preparations, NaCl 
often had a biphasic effect, causing substantially 
less inhibition in the presence of 150 mM NaCl 
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Table 1 
Effects of NaCl and 1-octadecyl-2-acetyl-G-3-PC on the adenylate cyclase activities of human platelet particulate 
fractions prepared in the presence and absence of EGTA 
Enzyme 
preparation 
Additions Adenylate cyclase activity 
(pmol.min-’ . mg protein-‘) 
Without With 
I-octadecyl-Z 1 -octadecyl-Z 
acetyl-G-3-PC acetyl-G-3-PC 
Inhibition of 
adenylate cyclase 
by 1 -octadecyl-Z 
acetyl-G-3-PC 
(Q) 
+ EGTA None 11.9 * 0.2 8.6 + 0.2 28 f 2 
NaCl 35.3 * 1.1 11.2 f 0.1 68 f 1 
PGEr 138.9 + 5.4 106.7 + 0.5 23 f 3 
NaCl + PGEr 150.7 * 1.7 82.6 f 1.3 45 f 1 
- EGTA None 31.7 * 1.3 26.5 f 0.6 16 k 4 
NaCl 19.1 * 0.7 12.5 f 0.6 35 + 4 
PGEr 373.1 + 12.2 359.1 k 18.7 4+6 
NaCl + PGEi 170.2 + 5.5 154.3 k 1.0 9+3 
Human platelets were lysed by freezing and thawing in the presence or absence of 5 mM EGTA and the particulate 
fractions were isolated immediately. Adenylate cyclase assays were carried out with the additions indicated. Final 
concentrations were: NaCl, 100 mM; PGEr, 200 nM; I-octadecyl-2-acetyl-G-3-PC, 400 nM. Values are means f SE 
from triplicate assays 
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Fig. 1. Effects of NaCl and l-octadecyl-2-acetyl-G-3-PC on the adenylate cyclase activities of particulate fractions 
0 50 100 150 
NaCl (mM) 
prepared from rabbit platelets lysed in 150 mM Tris-HCl (pH 7.4), containing no other additions (A), 5 mM EGTA 
(B) or 4OOpM leupeptin (C). All three lysates were incubated for 15 min at 25°C before isolation of the particulate 
fractions. Assays were carried out in the absence (open symbols) and presence (closed symbols) of 100 nM 
1-octadecyl-2-acetyl-G-3-PC. Inhibition of adenylate cyclase activity by this compound is shown in D, with additions 
during platelet lysis as follows: (0) none (from A); (A) EGTA (from B); (+) leupeptin (from C). 
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Fig.2. Effects of cu-chymotrypsin on the actions of NaCl and I-octadecyl-2-acetyl-G-3-PC on the adenylate cyclase 
activities of rabbit platelet particulate fractions. Platelet lysate containing 5 mM EGTA was incubated for 10 min at 
25°C with no additions (A), 2Opg of a-chymotrypsin/ml (B) or 50,~g of cu-chymotrypsin/ml (C). These incubations 
were terminated by addition of 500 pg of soybean trypsin inhibitor/ml and after 2 min the mixtures were cooled to 0°C. 
Particulate fractions were then isolated by centrifugation (38000 x g for 40 min) and washed twice by homogenization 
and re-centrifugation in buffer containing 10 mM Tris-HCI and 5 mM EGTA, pH 7.4. Assays were carried out in the 
absence (open symbols) and presence (closed symbols) of 100 nM 1-octadecyl-2-acetyl-G-3-PC. Inhibition of adenylate 
cyclase activity by this compound is shown in D for the following additions during incubations of the platelet lysate: 
(0) none (from A); (A) 20 pg of a-chymotrypsin/ml (from B); (+) 50 ,ug of a-chymotrypsin/ml (from C). 
than 50 mM NaCl (fig.lA). Addition of 100 nM 
l-octadecyl-2-acetyl-G-3-PC blocked the stimula- 
tion of adenylate cyclase by NaCl seen in par- 
ticulate fractions prepared with EGTA or leupep- 
tin, with the result that inhibition of the enzyme in- 
creased from 20-30% in the absence of NaCl to 
80-90% in the presence of 150 mM NaCl 
(fig. lB,C). The salt concentration required for 
half-maximal inhibition of adenylate cyclase by 
1-octadecyl-2-acetyl-G-3-PC was markedly in- 
creased by proteolysis (fig.lD). 
Incubation of rabbit platelet lysate containing 
5 mM EGTA with 5Opg of cu-chymotrypsin/ml 
prior to isolation of the particulate fraction 
resulted in an up to 6-fold stimulation of basal 
adenylate cyclase activity (fig.2A,C). Under these 
conditions, NaCl caused a more pronounced in- 
hibition of the enzyme than observed after en- 
dogenous proteolysis, probably because the 
stimulatory action of this salt was completely or 
almost completely lost. A biphasic effect of NaCl, 
similar to that usually observed after endogenous 
proteolysis, was obtained when a lower cy- 
chymotrypsin concentration was used (fig.2B). 
Pre-incubation of lysate with a-chymotrypsin 
diminished the inhibition of adenylate cyclase ac- 
tivity by 1-octadecyl-2-acetyl-G-3-PC in a dose- 
dependent manner (fig.2D); at 50,ug of pro- 
tease/ml, no inhibitory effect of this compound 
was detected in the absence of NaCl and only a 
weak inhibition was observed with 150 mM NaCl. 
The specificity of these actions of NaCl on rab- 
bit platelet adenylate cyclase was investigated by 
comparative studies with the chlorides of different 
monovalent cations (table 2). With non- 
proteolysed platelet particulate fractions, LiCl was 
stimulatory, although less so than NaCl, and KC1 
weakly inhibitory. However, with proteolysed 
preparations, both LiCl and KC1 were inhibitory. 
Choline-Cl had no effect on either preparation. 
These results show that neither the stimulatory nor 
inhibitory action of NaCl was attributable to an in- 
crease in the ionic strength of the medium or to 
Cl-. The effects of these salts on the adenylate 
cyclase activities of proteolysed and non- 
proteolysed human platelet particulate fractions 
(not shown) were very similar to those observed 
with rabbit material. 
16 
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Table 2 
Effects of different monovalent cations on the adenylate cyclase activities 
of non-proteolysed and proteolysed rabbit platelet particulate fractions 
Expt. Salt Concen- Adenylate cyclase activity 
tration (070 change) 
(mM) 
Non-proteolysed Proteolysed 
enzyme enzyme 
1 NaCl 30 +107 Z!Z 5 -37f 1 
150 +489 f 20 +18+3 
LiCl 30 +22+ 4 -17k2 
150 +83+ 5 -14+3 
KC1 30 - 6k 3 -14+1 
150 - 13* 2 -37 + 5 
Choline-Cl 30 + If 3 - Sk2 
150 o* 3 - 8+3 
2 NaCl 30 +66* 7 -37 f 4 
150 +295 f 15 -24 + 2 
LiCl 30 + 6k 5 -15*2 
150 +56i 5 -37k2 
KC1 30 - 17* 3 -15+2 
150 -22* 3 -35 + 2 
Choline-Cl 30 - ll+ 5 - 5+4 
150 - 9* 4 - 2k4 
In expt.1, platelets lysed in the presence or absence of EGTA were 
incubated for 15 min at 25°C before isolation of the particulate 
fractions. Control activities of non-proteolysed (+ EGTA) and 
proteolysed (- EGTA) particulate fractions were 19.6 + 0.5 and 66.4 f 
0.3 pmol cAMP.min-‘.mg protein-‘, respectively. In expt.2, platelet 
lysate containing EGTA was incubated with or without 5Opg of cy- 
chymotrypsin/ml for 10 min at 25°C before isolation of particulate 
fractions as described in the legend to fig.2. Control activities of non- 
proteolysed and proteolysed preparations were 40.3 + 1.3 and 162 f 
3 pmol CAMP. mint. mg protein-‘. All values are means + SE from 
triplicate assays 
4. DISCUSSION 
Omission of EGTA from the platelet lysis buffer 
had 3 major effects on the adenylate cyclase ac- 
tivities of human and rabbit platelet particulate 
fractions: basal activity was increased, stimulation 
of activity by NaCl was replaced by inhibition and 
the inhibitory effect of I-octadecyl-2-acetyl- 
G-3-PC was diminished. Several lines of evidence 
indicated that these changes in enzyme activity 
resulted from Ca2+-dependent proteolysis of the 
platelet membrane. Thus, two forms of 
Ca2+-dependent protease have been identified in 
platelets [lo] and leupeptin, a potent inhibitor of 
this enzyme [l 11, had the same effects as chelation 
of platelet Ca2+ by EGTA. Moreover, incubation 
of the platelet lysate with cu-chymotrypsin in the 
presence of EGTA led to essentially the same 
results as omission of EGTA. The results in [2], 
where it was found that incubation of platelet 
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lysate with added CaC12 enhanced adenylate 
cyclase activity, are in accord with our conclusion. 
Our findings suggest that the inhibition of 
adenylate cyclase by NaCl previously observed 
with membranes from platelets [8,9] and 
neuroblastoma x glioma hybrid cells [12] was due 
to limited proteolysis of these membranes during 
their isolation. It may be possible to use this in- 
hibitory effect of NaCl on adenylate cyclase as an 
indicator of proteolytic membrane alteration in a 
variety of biological systems. 
The two opposite effects of NaCl on platelet 
adenylate cyclase activity that we have observed, 
together with their different cation specificities, 
suggest hat NaCl may act at two different sites. 
This conclusion is consistent with evidence that 
NaCl inhibits the effects of both the Ni and N, 
GTP-binding proteins in adipocyte membranes 
[13]. Several studies have shown that limited pro- 
teolysis can selectively eliminate the function of the 
Ni protein [3,4,13]. Our results are in agreement 
with these findings since the inhibitory action of 
1 -octadecyl-2-acetyl-G-3-PC on platelet adenylate 
cyclase, which we have shown to be GTP- 
dependent [ 141, was largely abolished by pro- 
teolysis, whereas the stimulatory action of PGEi 
was unaffected. Because inhibition by NaCl was 
only observed after proteolysis, when Ni-mediated 
effects were absent or reduced, it is possible that 
this action of NaCl is attributable to inhibition of 
N, function. Conversely, the stimulatory effect of 
NaCl, which was reversed by 1-octadecyl-2-acetyl- 
G-3-PC, could be exerted through Ni, as suggested 
in [13]. However, this hypothesis does not explain 
why the stimulation of basal adenylate cyclase ac- 
tivity by NaCl requires a lower GTP concentration 
than the reversal of this effect by 
1-octadecyl-2-acetyl-G-3-PC [ 141. 
These studies show the importance of 
eliminating Ca*+-dependent proteolysis during and 
after lysis of platelets in obtaining an optimal hor- 
monal inhibition of particulate fraction adenylate 
cyclase. They also show, for the first time, that 
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NaCl stimulates the activity of the platelet enzyme, 
provided proteolysis is prevented, and enhances 
the inhibitory effect of 1-octadecyl-2-acetyl- 
G-3-PC. Under optimal conditions, this agonist 
caused up to 68 and 90% inhibitions of the 
adenylate cyclase activities of human and rabbit 
preparations, respectively. 
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